NIH: Inhaled moisturizing drug boosts lung function in severe COPD
By
Alicia Lasek
Feb 02, 2021
The biologic drug hyaluronan improved lung function in patients hospitalized for severe exacerbation of chronic obstructive pulmonary disease, a new study finds.
NIH falls prevention study shows no difference from usual care
By
Alicia Lasek
Jul 09, 2020
A managed, individualized prevention plan did not appear to affect the length of time to a new, serious fall. The study involved 5,000 at-risk adults.
Clinical briefs for Friday, Dec. 9
By
Alicia Lasek
Dec 09, 2022
Next health emergency to reveal impact of patient visitor law … $11M NIH grant to support evaluation of Alzheimer’s screening tool in primary care … COVID rebound uncommon among patients treated...
Nurse-led quality program improves care of older adults
By
Alicia Lasek
Nov 04, 2019
The NICHE program of the NYU Rory Meyers College of Nursing has proven successful in a number of key areas, say researchers.
Clinical briefs for Tuesday, Aug. 17
By
Alicia Lasek
Aug 17, 2021
NIH: A single skills-based class relieves lower back pain … Still no mandate, but Pennsylvania wants 80% of SNF workers vaccinated by October … Federal scientists develop faster COVID-19 test … APIC...
NIH: Temperature-stable TB vaccine found safe, effective in trial
By
Alicia Lasek
Mar 07, 2023
A temperature-stable tuberculosis vaccine that lasts for months in storage is safe and effective in healthy adults, according to the results of a new trial.
NIH: ‘Good’ cholesterol may not universally predict heart disease risk
By
Alicia Lasek
Nov 28, 2022
In a study of 23,000 people, high HDL cholesterol levels were not associated with reduced cardiovascular disease risk, and low levels predicted increased heart disease in white but not Black adults.
FDA nixes use of Parkinson’s drug Nuplazid for treating Alzheimer’s psychosis
By
Alicia Lasek
Aug 08, 2022
The Food and Drug Administration has decided not to approve an expanded use of the psychosis drug pimavanserin (Nuplazid) to treat patients with Alzheimer’s.
Feds look to OTC drugs for self-treatment of mild, moderate COVID
By
Alicia Lasek
Apr 21, 2021
A large trial is set to study the potential for repurposed, over-the-counter drugs to treat mild-to-moderate COVID-19 symptoms. If found effective, the approval timeline will likely be short, according...
U.S. invests $1 billion in a vaccine candidate; NIH tests multiple COVID-19 treatments
By
Alicia Lasek
Aug 07, 2020
One hundred million doses of the experimental vaccine will be stockpiled. The deal increases the likelihood that the United States will have at least one safe, effective vaccine by 2021, HHS Secretary...